Showing results (241-250 of 308) with videos related to
Sort By:
Pageof 31
Wellcome Open Research|January 22, 2025
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping ReviewMaide Barış, Xiu Lim, Melanie T Almonte, et al.Viruses|January 8, 2025
Findings from a Project Which Established Hepatitis C Point-of-Care Testing and Linkage to Care at a Homelessness Service in Adelaide, Australia, 2021-2022Erin M McCartney, Joshua Dawe, Lucy Ralton, et al.Protein Science : a Publication of the Protein Society|February 1, 2011
Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structuresAndreas Kuglstatter, April Wong, Stan Tsing, et al.Plos One|September 7, 2016
Prevalence of Liver Fluke (Fasciola hepatica) in Wild Red Deer (Cervus elaphus): Coproantigen ELISA Is a Practicable Alternative to Faecal Egg Counting for Surveillance in Remote PopulationsAndrew S French, Ruth N Zadoks, Philip J Skuce, et al.Hepatology (Baltimore, Md.)|September 18, 2016
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II studyMarianne Martinello, Edward Gane, Margaret Hellard, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|March 3, 2025
Heart Transplantation and Donation After Circulatory Death in Children. A Review of the Technological, Logistical and Ethical FrameworkLouise Amelia Kenny, Liz Armstrong, Marius Berman, et al.Healthcare (Basel, Switzerland)|June 19, 2024
Exploring the Health-Related Quality of Life and the Lived Experience of Adolescents Following Invasive Meningococcal DiseaseMark McMillan, Joshua McDonough, Margaret Angliss, et al.Resuscitation|August 19, 2021
Ethics of ECPR researchMartje M Suverein, David Shaw, Roberto Lorusso, et al.Vaccine|September 3, 2008
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjectsBruno Guy, Nolwenn Nougarede, Sarah Begue, et al.The Lancet. Gastroenterology & Hepatology|April 19, 2017
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trialTania M Welzel, Tarik Asselah, Emily O Dumas, et al.Pageof 31